Tag: Prostate Cancer Diagnostics Market insights

250 Pages Prostate Cancer Treatment Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Prostate Cancer Treatment to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Prostate Cancer Treatment market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=58

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Prostate Cancer Treatment market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Prostate Cancer Treatment

According to Fact.MR, the global market for Prostate Cancer Treatment was valued at around US$ 3 Bn in 2020 and is projected to expand at a staggering CAGR of over 10% through 2031. The market is expected to surpass a staggering value of US$ 8 Bn by 2031.

The report offers actionable and valuable market insights of Prostate Cancer Treatment. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Prostate Cancer Treatment Market across various industries and regions

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=58

Key Segments Covered

• Test Type

  • PSA Prostate Cancer Diagnostic Tests
  • PCA3 Prostate Cancer Diagnostic Test
  • CTC  Prostate Cancer Diagnostic Tests
  • Immunohistochemistry Prostate Cancer Diagnostic Test

• By End User

  • Prostate Cancer Diagnostics in Hospitals
  • Prostate Cancer Diagnostics in Independent Diagnostic Laboratories
  • Prostate Cancer Diagnostics in Cancer Research Institutes
  • Prostate Cancer Diagnostics in Other Settings

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/58

Key Takeaway from the Market Study

• By test type, PSA tests likely to surpass US$ 270 Mn in value by 2021-end
• Demand for PCA-3 tests to soar, expected to exceed a valuation of US$ 284 Mn by 2031
• CTC tests acquiring popularity, poised to surpass US$ 141 Mn by 2021-end
• Diagnostic tests across hospitals and research institutes to collectively expand at 15% CAGR
• U.S to emerge as an opportunistic market, registering a CAGR of around 9%
• China to generate 40% demand for prostate cancer diagnostics across East Asia

“Changing lifestyles, awareness regarding prostate cancer and use of artificial intelligence for prostate cancer diagnostics are expected to uplift demand for prostate cancer diagnostics in coming years.” comments the Fact.MR analyst.

Competitive Landscape

Prominent prostate cancer diagnostics providers include Abbott Laboratories, AstraZeneca Plc., Danaher Corporation, Vyant Bio Inc., Biocept Inc., Becton Dickinson & Company, Agilent Technologies and Myriad Genetics Inc. to name a few.

• In June 2021, Biocept Inc. was awarded a South Korean patent for its Primer-Switch technology, which detects rare mutations in circulating tumor DNA (ctDNA) using RT-PCR. This patent is titled Methods for Detecting Nucleic Acid Sequence Variants
• Likewise, in March 2021, Myriad Genetics joined forces with Intermountain Precision Genomics for a comprehensive offering of germline and somatic tumor testing services for detecting advanced hereditary cancers, including prostate cancer

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

• Prostate Cancer Treatment Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
• Prostate Cancer Treatment Historical volume analysis: The report provides a comparison of Prostate Cancer Treatment’s historical sales and projected sales performance for 2021-2031.
• Prostate Cancer Treatment Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Prostate Cancer Treatment market. It carefully gauges the impact of changing healthcare needs of key demographics globally
• Prostate Cancer Treatment Consumption by demographics: The report investigates consumer behavior affecting Prostate Cancer Treatment demand outlook for the assessment period. Effect of their keenness for digital trends on Prostate Cancer Treatment market is carefully analyzed
• Post COVID consumer spending on Prostate Cancer Treatment: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Prostate Cancer Treatment market growth.

More Valuable Insights on Prostate Cancer Treatment Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Prostate Cancer Treatment, Sales and Demand of Prostate Cancer Treatment, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

According to the latest report by Fact.MR, the global demand for prostate cancer diagnostics is anticipated to exhibit a steady expansion at 5.3% CAGR during the forecast period 2017 to 2022. In terms of revenues, the market is projected to reach US$ 823.5 Mn in 2017; by 2022 this number is projected to surpass US$ 1,000 Mn.

Diagnosis of prostate cancer is becoming a critical undertaking for medical organizations. Newer treatments on prostate cancer are being developed by considering the scope of diagnostic approach. This emergence of diagnosis-associated treatments on prostate cancer is expected to render higher medical efficiency, providing effective outputs at minimal healthcare spending.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=58

Through and through, medical organizations are scanning key criteria associated with diagnosis of prostate cancer, tracking parameters such as age of the patient, ethnicity, family medical history, and diet. Considering the sensitivity of organs in the prostate area, patients are also adopting non-invasive diagnosis tests, which is ultimately impacting the products sold in the global market for prostate cancer diagnostics.

Key players in the global market for prostate cancer diagnostics include

Abbott Laboratories
Biocept, Inc.
AstraZeneca plc.
Cancer Genetics, Inc.
Danaher Corporation
Bayer Aktiengesellschaft
Becton
Dickinson and Company
Agilent Technologies
Foundation Medicine, Inc.
Myriad Genetics Inc.

Global Prostate Cancer Diagnostics Market: Segmentation

For clearer understanding of the Prostate Cancer Diagnostics Market, analysts have segmented the market. The segmentation has been done on the basis of application, technology, and users. Each segment has been further explained with the help of graphs figures. This breakdown of the market gives the readers an objective view of the global Prostate Cancer Diagnostics Market, which is essential to make sound investments.

A market research study is incomplete without regional analysis, and we are well aware of it. That is why, the report includes a comprehensive and all-inclusive study that solely concentrates on the geographical growth of the global Prostate Cancer Diagnostics Market.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=58

5 Estimations from Fact.MR’s Report on the Global Prostate Cancer Diagnostics Market

1. North America will continue to be the most lucrative region in the global prostate cancer diagnostics market, in terms of revenues. The prostate cancer diagnostics market in North America and Europe are expected to exhibit similar CAGRs through 2022.
2. The market in Asia-Pacific excluding Japan (APEJ) is expected to register the fastest expansion through 2022. In contrast, prostate cancer diagnostics market in Middle East & Africa will continue to register a sluggish expansion during the forecast period.
3. PSA tests will continue to be the largest adopted tests for diagnosis of prostate cancer across the globe. PSA test segment is projected to register the highest CAGR in the market through 2022.
4. Hospital-associated labs are expected to remain the largest end-users of prostate cancer diagnostics in the global market, however revenues from prostate cancer diagnostics in hospital-associated labs will register the lowest CAGR in the market through 2022.
5. In terms of revenues, cancer research institutes are expected to register the highest CAGR in the market through 2022. Independent diagnostics labs will remain the second largest end users of the prostate cancer diagnostics during the forecast period.

The study also includes accurate estimations about market growth at the global, regional, and country levels. It empowers you to understand why some regional markets are flourishing while others are seeing a decline in growth. It also allows you to focus on geographies that hold the potential to create lucrative prospects in the near future.

By Test Type

• PSA Tests
• CTC Tests
• Immunohistochemistry
• PCA3 test

By End User

• Hospital Associated Labs
• Independent Diagnostic Laboratories
• Cancer Research Institutes

Following Questions Answers Covered in the Report are:

• How will the global Prostate Cancer Diagnostics Market perform during the forecast period? What will be the market size in terms of value and volume?
• Which segment will drive the global Prostate Cancer Diagnostics Market? Which regional market will show extensive growth in the future? What are the reasons?
• How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
• What are the key strategies adopted by players to sustain themselves in the global Prostate Cancer Diagnostics Market?
• How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=58

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
• EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
• CIS & Russia
• Japan
• Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
• Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –http://www.globenewswire.com/en/news-release/2020/03/06/1996513/0/en/Fact-MR-Projects-Global-Sleep-Mask-Sales-to-Grow-at-4-CAGR-over-2019-2029-Wrap-around-Sleep-Masks-Emerging-Lucrative.html

The Report Covers Exhaustive Analysis On:

• Market Segments
• Market Dynamics
• Market Size & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain